Alcista
$36.73
Precio del escenario
$28.160
+1.025 (+3.64%)Al cierre
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
Celsius Holdings Inc is currently priced at $28.58, which is below the average analyst price target of $42, indicating potential upside. However, the stock has a high forward P/E of 16.86, suggesting it may be overvalued given its recent performance, with a year-to-date change of -40.15%. Additionally, the RSI is at 65.16, indicating it is nearing overbought territory. The main risk is the recent class action lawsuit, which could negatively impact investor sentiment.
Morgan Stanley
$42
2026-09-17
Morgan Stanley
2026-09-17
Precio objetivo
$42
Deutsche Bank
$35
2026-08-27
Deutsche Bank
2026-08-27
Precio objetivo
$35
Goldman Sachs
$45
2026-08-10
Goldman Sachs
2026-08-10
Precio objetivo
$45
Stephens
$50
2026-08-10
Stephens
2026-08-10
Precio objetivo
$50
Morgan Stanley
$42
2026-08-07
Morgan Stanley
2026-08-07
Precio objetivo
$42
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Celsius Holdings Class Action Reminder

Celsius Holdings Class Action Lawsuit Announcement

Analysis of Monster Beverage's Competitive Advantages

Monster Beverage's Unique Debt-Free Advantage

Celsius Faces Policy and Economic Challenges
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).
Celsius Holdings Inc is currently priced at $28.58, which is below the average analyst price target of $42, indicating potential upside. However, the stock has a high forward P/E of 16.86, suggesting it may be overvalued given its recent performance, with a year-to-date change of -40.15%. Additionally, the RSI is at 65.16, indicating it is nearing overbought territory. The main risk is the recent class action lawsuit, which could negatively impact investor sentiment.
1 analysts cover CELH: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 62.85.

$CELH could realistically consolidate until June 2027. It has about 8 months of room left before it reaches the apex of this massive symmetrical triangle, before it could break out and start the next bull run or leg up. Not financial advice, just food for thought. Shares are probably the best way to go to avoid theta decay.
Mostrar más
$CELH below $30 isn't an attractive short. It's a $100 stock with a good COO.
Mostrar más
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.